BACKGROUND: Type 2 diabetes mellitus is a worldwide healthcare problem with major socioeconomic implications. Metabolic surgical procedures have been shown to improve diabetes, but the mechanism of action is poorly understood. The Goto-Kakizaki (GK) rodent is a type 2 diabetic animal model that is ideally situated for studying the effect of surgery on diabetes; however, the operative mortality is high. The aim of this study was to describe the operative technique, improvements in perioperative management, and the technique of micro-positron emission tomography (PET) scanning of the beta-cell mass in GK rodents. METHODS: A total of 53 GK rats were divided into 1 of 3 operative groups: sham, sleeve gastrectomy, and duodenojejunal bypass. A subset of animals underwent micro-PET scanning with [11C]-dihydrotetrabenazine to determine the vesicular monoamine transporter 2 binding index, an indicator of beta-cell mass. RESULTS: The 30-day mortality in the sham and sleeve gastrectomy rodents was 0; however, 2 sleeve gastrectomy rodents developed enterocutaneous fistula and 1 developed an abscess. In the duodenojejunal bypass group, the initial mortality rate was close to 90%; however, refinements in the surgical technique and perioperative management (fluids, antibiotics, pain control) lowered the mortality rate to 60%. The surgical technique is discussed in detail. [11C]-Dihydrotetrabenazine uptake in the pancreas was demonstrated on micro-PET scanning in the sham and duodenojejunal bypass rodents. CONCLUSION: Intensive medical management in the perioperative period and attention to the operative technique lowered the mortality. [11C]-Dihydrotetrabenazine micro-PET scanning is a feasible method for assessing the beta-cell mass in GK rodents and could prove to be an important modality for evaluating beta-cell performance in type 2 diabetes.
BACKGROUND:Type 2 diabetes mellitus is a worldwide healthcare problem with major socioeconomic implications. Metabolic surgical procedures have been shown to improve diabetes, but the mechanism of action is poorly understood. The Goto-Kakizaki (GK) rodent is a type 2 diabetic animal model that is ideally situated for studying the effect of surgery on diabetes; however, the operative mortality is high. The aim of this study was to describe the operative technique, improvements in perioperative management, and the technique of micro-positron emission tomography (PET) scanning of the beta-cell mass in GK rodents. METHODS: A total of 53 GK rats were divided into 1 of 3 operative groups: sham, sleeve gastrectomy, and duodenojejunal bypass. A subset of animals underwent micro-PET scanning with [11C]-dihydrotetrabenazine to determine the vesicular monoamine transporter 2 binding index, an indicator of beta-cell mass. RESULTS: The 30-day mortality in the sham and sleeve gastrectomy rodents was 0; however, 2 sleeve gastrectomy rodents developed enterocutaneous fistula and 1 developed an abscess. In the duodenojejunal bypass group, the initial mortality rate was close to 90%; however, refinements in the surgical technique and perioperative management (fluids, antibiotics, pain control) lowered the mortality rate to 60%. The surgical technique is discussed in detail. [11C]-Dihydrotetrabenazine uptake in the pancreas was demonstrated on micro-PET scanning in the sham and duodenojejunal bypass rodents. CONCLUSION: Intensive medical management in the perioperative period and attention to the operative technique lowered the mortality. [11C]-Dihydrotetrabenazine micro-PET scanning is a feasible method for assessing the beta-cell mass in GK rodents and could prove to be an important modality for evaluating beta-cell performance in type 2 diabetes.
Authors: Ricardo V Cohen; Carlos A Schiavon; José S Pinheiro; Jose Luiz Correa; Francesco Rubino Journal: Surg Obes Relat Dis Date: 2007 Mar-Apr Impact factor: 4.734
Authors: J Vidal; A Ibarzabal; J Nicolau; M Vidov; S Delgado; G Martinez; J Balust; R Morinigo; A Lacy Journal: Obes Surg Date: 2007-08 Impact factor: 4.129
Authors: Norman Ray Simpson; Fabiola Souza; Piotr Witkowski; Antonella Maffei; Anthony Raffo; Alan Herron; Michael Kilbourn; Agata Jurewicz; Kevan Herold; Eric Liu; Mark Adam Hardy; Ronald Van Heertum; Paul Emerson Harris Journal: Nucl Med Biol Date: 2006-10 Impact factor: 2.408
Authors: Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux Journal: Ann Surg Date: 2006-11 Impact factor: 12.969
Authors: A L DePaula; A L V Macedo; N Rassi; S Vencio; C A Machado; B R Mota; L Q Silva; A Halpern; V Schraibman Journal: Surg Endosc Date: 2008-03-18 Impact factor: 4.584
Authors: David Pacheco; Daniel Antonio de Luis; Alejandro Romero; Manuel González Sagrado; Rosa Conde; Olatz Izaola; Rocío Aller; Alberto Delgado Journal: Am J Surg Date: 2007-08 Impact factor: 2.565
Authors: Alberto Patriti; Maria Cristina Aisa; Claudia Annetti; Angelo Sidoni; Francesco Galli; Ivana Ferri; Nino Gullà; Annibale Donini Journal: Surgery Date: 2007-07 Impact factor: 3.982
Authors: Fabiola Souza; Norman Simpson; Anthony Raffo; Chitra Saxena; Antonella Maffei; Mark Hardy; Michael Kilbourn; Robin Goland; Rudolph Leibel; J John Mann; Ronald Van Heertum; Paul E Harris Journal: J Clin Invest Date: 2006-05-18 Impact factor: 14.808
Authors: Víctor Valentí; Marina Martín; Beatriz Ramírez; Javier Gómez-Ambrosi; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Andoni Lancha; Secundino Fernández; Javier A Cienfuegos; María A Burrell; Gema Frühbeck Journal: Obes Surg Date: 2011-09 Impact factor: 4.129
Authors: William B Inabnet; Luca Milone; Paul Harris; Evren Durak; Matthew J Freeby; Leaque Ahmed; Manu Sebastian; Jean-Christophe Lifante; Marc Bessler; Judith Korner Journal: Surgery Date: 2009-10-13 Impact factor: 3.982